Liver involvement revealing systemic mastocytosis: Report of two cases;Mastocytose systémique avec atteinte hépatique révélatrice

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 1, 2004, Pages 80-83

  Wendum, Dominique ^a   Prevot, Sophie ^a   Poujol Robert, Armelle ^b   Rosmorduc, Olivier ^b   Cabane, Jean ^b   Fouillard, Loïc ^b   Flejou, Jean François ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR; TRYPTASE;

AGED; ARTICLE; CASE REPORT; CELL INFILTRATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAUNDICE; LIVER DISEASE; LIVER FAILURE; LIVER SINUSOID; MALE; MAST CELL; SYSTEMIC MASTOCYTOSIS; TISSUE SECTION;

EID: 1542374507     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94851-8     Document Type: Article

References (16)

1. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25.
2. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96:2S-4S.
3. Bain BJ. Systemic mastocytosis and other mast cell neoplasms. Br J Haematol 1999;106:9-17.
4. Sperr WR, Horny HP, Valent P. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis. Int Arch Allergy Immunol 2002;127:140-2.
5. Mican JM, Di Bisceglie AM, Fong TL, Travis WD, Kleiner DE, Baker B, et al. Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases. Hepatology 1995;22:1163-70.
6. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 2000;14:579-623.
7. Safyan EL, Veerabagu MP, Swerdlow SH, Lee RG, Rakela J. Intrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature. Am J Gastroenterol 1997;92:1197-200.
8. Kyriakou D, Kouroumalis E, Konsolas J, Oekonomaki H, Tzardi M, Kanavaros P, et al. Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis - report of four cases. Am J Gastroenterol 1998;93:106-8.
9. Li CY, Baek JY. Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol 2002;127:123-6.
10. Baron TH, Koehler RE, Rodgers WH, Fallon MB, Ferguson SM. Mast cell cholangiopathy: another cause of sclerosing cholangitis. Gastroenterology 1995;109:1677-81.
11. Horny HP, Kaiserling E, Campbell M, Parwaresch MR, Lennert K. Liver findings in generalized mastocytosis. A clinicopathologic study. Cancer 1989;63:532-8.
12. Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-40.
13. Natkunam Y, Rouse RV. Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow. Am J Surg Pathol 2000;24:81-91.
14. Worobec AS, Metcalfe DD. Mastocytosis: current treatment concepts. Int Arch Allergy Immunol 2002;127:153-5.
15. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-4.
16. Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, et al. The c-KIT mutation causing human mastocytosis is resistant to ST1571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002;99:1741-4.